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Abstract
Background Thyroid surgery is often performed, especially in young female patients. As patient satisfaction become more 
and more important, different extra-cervical “remote” approaches have evolved to avoid visible scars in the neck for bet-
ter cosmetic outcome. The most common remote approaches are the transaxillary and retroauricular. Aim of this work is 
to compare Endoscopic Cephalic Access Thyroid Surgery (EndoCATS) and axillo-bilateral-breast approach (ABBA) to 
standard open procedures regarding perioperative outcome and in addition to control cohorts regarding quality of life (QoL) 
and patient satisfaction.
Methods In a single center, 59 EndoCATS und 52 ABBA procedures were included out of a 2 years period and compared 
to 225 open procedures using propensity-score matching. For the endoscopic procedures, cosmetic outcome, patient satis-
faction and QoL (SF-12 questionnaire) were examined in prospective follow-up. For QoL a German standard cohort and 
non-surgically patients with thyroid disease were used as controls.
Result The overall perioperative outcome was similar for all endoscopic compared to open thyroid surgeries. Surgical time 
was longer for endoscopic procedures. There were no cases of permanent hypoparathyroidism and no significant differences 
regarding temporary or permanent recurrent laryngeal nerve (RLN) palsies between open and ABBA or EndoCATS pro-
cedures (χ2; p = 0.893 and 0.840). For ABBA and EndoCATS, 89.6% and 94.2% of patients were satisfied with the surgical 
procedure. Regarding QoL, there was an overall significant difference in distribution for physical, but not for mental health 
between groups (p < 0.001 and 0.658). Both endoscopic groups performed slightly worse regarding physical health, but 
without significant difference between the individual groups in post hoc multiple comparison.
Conclusion Endoscopic thyroid surgery is safe with comparable perioperative outcome in experienced high-volume centers. 
Patient satisfaction and cosmetic results are excellent; QoL is impaired in surgical patients, as they perform slightly worse 
compared to German standard cohort and non-surgical patients.
Keywords EndoCATS · Endoscopic thyroid surgery · Remote approach thyroid surgery · Retroauricular approach · 
Transaxillary approach · ABBA
Over the past decades, thyroid surgery developed to one 
of the safest procedures in surgery with low morbidity and 
mortality. As thyroid surgery is performed in a high num-
ber of young and female patients, recently different extra-
cervical so called “remote” approaches have evolved. Using 
these techniques, a visible scar in the neck is avoided for 
better cosmetic outcome (cosmetics), as quality of life and 
patient satisfaction become more and more important out-
come variables in surgery [1–9]. The most common remote 
approaches are the transaxillary and retroauricular approach 
(RA) [4–6, 8, 10–24], both can be used for endoscopic and 
robotic procedures. All remote-access techniques have 
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unique benefits but also some disadvantages and therefore 
need a careful patient selection for morphologic and disease 
specific factors [1–3, 11, 22, 25–27].
The RA was first described by our group in 2008 as the 
EndoCATS approach and has even spread worldwide [5, 20, 
21, 26]. It was also modified to a robotic “face-lift” approach 
[8, 24]. Its advantage lies in the smaller dissection area due 
to the short distance between retroauricular incision and 
the thyroid; specimen up to 60 mL volume can be retrieved 
through this access, but only unilateral thyroidectomy pro-
cedures can be performed [5, 6]. The axillo-bilateral-breast 
approach (ABBA) was first described in 2003 by Shimazu 
et al. and can be used for bilateral procedures. The view on 
the thyroid gland and the important landmarks are compa-
rable to open surgery because of the ventral access after 
dividing the strap muscles in the midline and an excellent 
exposure with use of  CO2—insufflation [13]. Large speci-
men can be retrieved through the axillar access [4, 8, 12, 13, 
15, 17]. Since its development, ABBA was also introduced 
in Germany by Strik et al, who published their first experi-
ence 13 years ago [19]. More recent, experience with these 
techniques and robotic variants like bilateral-axillary-breast 
approach (BABA) and the RA steadily improved and they 
can even be used in oncologic thyroid surgery with central 
lymphadenectomy in low-risk and localized differentiated 
thyroid cancer [15, 28, 29]. Complication rates are similar to 
open thyroid surgery with a comparable oncologic outcome 
and better cosmetic satisfaction due to the extra-cervical 
scar [2, 3, 6, 10, 11, 15–17, 21, 25, 27, 29]. In total, endo-
scopic thyroid surgery and its robotic variants are technically 
advanced surgical procedures, which should be performed 
by experienced hands not only because of the prolonged 
learning curve in comparison to open thyroid surgery [3]. 
After developing the EndoCATS in our surgical depart-
ment [5], we introduced ABBA as well for bilateral thyroid 
pathologies and complete thyroidectomies in 2009. Due to 
relevant incidence of incidentally found papillary thyroid 
carcinoma with bilateral or multifocal tumors [30, 31] as 
well as other bilateral pathologies of the thyroid gland, a 
scarless endoscopic technique not only for unilateral but also 
bilateral thyroidectomies is needed in a specialized surgical 
department.
Our aim in this work was to compare both endoscopic 
techniques to standard open procedures regarding periopera-
tive outcome and in addition to control cohorts regarding 
quality of life and patient satisfaction.
Materials and methods
This study was approved by the local institutional review 
board. We performed a prospective comparison of the 
two endoscopic approaches. Fifty-nine EndoCATS and 52 
ABBA procedures were included from the same two-year 
time period. A total of 225 open procedures of a correspond-
ing time period are included for comparison regarding the 
perioperative outcome.
Perioperative data (patient characteristics, extent of resec-
tion, time of surgical procedure, perioperative complica-
tions, patho-histologic result) were collected. The extent of 
resection was sub-divided into near-total, sub-total, total thy-
roidectomy procedures or Dunhill procedure. Patients who 
underwent endoscopic surgery were invited for prospective 
follow-up examination and asked to complete questionnaires 
for quality of life (SF-12 questionnaire), grading of cosmetic 
result and patient satisfaction. Perioperative complications 
were subdivided in general complications (bleeding, tem-
porary or permanent RLN palsy, temporary or permanent 
hypoparathyroidism) and access-related complications 
(wound infection, local hematoma, pain or numbness in 
access area assigned to specific nerves if possible, acciden-
tal injury of anatomic structures). Hypoparathyroidism was 
defined as a drop in blood parathyroid hormone levels (PTH) 
below regular limits (< 10 ng/mL), regardless of the pres-
ence of typical hypocalcemic symptoms. A persistence for 
longer than six months after surgery, of pain, hypoparathy-
roidism or RLN palsy were defined as permanent.
The SF-12 questionnaire was chosen, as it is a reliable 
and validated instrument for life quality measurement and 
feasible due to its limited number of items [32, 33]. The 
SF-12 scoring results for physical and mental health com-
posite scales were compared to a collective of patients with 
known thyroid disease but without surgical therapy from 
our hospital’s outpatient department and a validated, healthy 
representative German cohort. A questionnaire for patient’s 
satisfaction and cosmetic outcome was used (Table 1).
Preoperative patient preparation and patient 
selection
The patients were informed about the operative techniques 
(ABBA, EndoCATS, conventional open thyroid surgery) 
and allocated to groups depending on the thyroid disease, 
extent of resection, patients’ preference and medical reasons. 
Indication for surgery and extent of thyroid resection were 
decided according to national and International guidelines 
[34, 35]. All patients signed informed consent for surgery 
and underwent routine preoperative evaluation using ultra-
sound, thyroid hormone tests and if needed fine needle aspi-
ration for cytology. A laryngoscopy was performed in all 
patients to evaluate vocal cord function.
For all surgical procedures neuromonitoring (Avalanche, 
Dr. Langer Medical, Waldkirch, Germany) was used. For 
open surgery, mono- and bipolar electrocoagulation and Vic-
ryl sutures (Ethicon, Norderstedt, Germany) were used. The 
open procedures were performed in a conventional surgical 
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technique. For endoscopic procedures, a standard laparo-
scopic equipment (Karl Storz SE and Co. KG, Tuttlingen, 
Germany) and vessel sealing devices (Ultracision, Ethicon 
Endo-Surgery Inc., J&J Medical Devices, Cincinnati, Ohio, 
USA) and a bipolar clamp were used. EndoCATS was per-
formed in a modification to our previous description [5, 6, 
36], since we used an approach above or ventral the ster-
nocleidomastoid muscle then distally passing between the 
sternal and clavicular head to reach the surgical space of 
de Quervain to avoid damage to the accessory nerve [36]. 
ABBA was performed similar to the technique described by 
Bährlehner et al. [4]. All patients were screened for hoarse-
ness postoperatively and were advised to undergo laryngo-
scopy after surgery.
For statistical analysis SPSS Statistics 25 (IBM, Armonk, 
NY, USA) and for graphical illustration Prism 8 (GraphPad 
Software, CA, USA) was used. Descriptive statistics and 
calculation of mean values were used to summarize patient 
characteristics and perioperative data.
Propensity score (PS) matching was performed to mini-
mize confounding bias and generate more reliable results 
[37] using XLSTAT (Addinsoft, Paris, France). A 1:1 match-
ing without replacement using a greedy algorithm and a 
caliper distance of 0.1 standard deviations of the logit of 
the propensity score was performed. The following preex-
isting confounders were used for matching because of pos-
sible impact on surgical outcome: sex, unilateral vs. bilateral 
procedures and extent of resection (near-total, sub-total, total 
or Dunhill procedure). Groups were compared with the non-
parametric Mann–Whitney U-test or Kruskal–Wallis one-
way analysis of variance (ANOVA) with Bonferroni cor-
rection for multiple comparisons, as the Shapiro–Wilk test 
showed that the metric data were not normally distributed. 
For comparison of SF-12 data, additionally the effect size 
after Cohen was calculated as the data at least visually 
approached a normal distribution. For comparison of data 
between groups concerning nominal or categorical data, we 
used the χ2 test and Fisher’s exact test for analysis with small 
case numbers. Pearson correlation was used to test relations 




An overview of all demographic and perioperative data of 
the conventional open group before and after PS match-
ing compared to endoscopic groups gives Table 2. Patients 
treated with the endoscopic techniques are significantly 
younger (KW: p < 0.001) compared to those treated with 
open surgical technique. After propensity score matching, 
sex is distributed equally between open and endoscopic pro-
cedures (χ2; p = 0.757). While at least a few men (8.5%) were 
operated with EndoCATS, the ABBA procedure was only 
performed in female patients because of the bilateral breast 
approach.
The distribution of ASA score differed significantly 
between open and endoscopic groups (χ2; p = 0.005) due 
to patient selection of young and predominantly healthy 
female patients for remote-access thyroid surgery. Rates 
for uni- and bilateral resections are distributed significantly 
different between groups despite propensity score match-
ing (χ2; p = 0.043), as a large amount of endoscopically per-
formed procedures are hemithyroidectomies (62.2%). The 
extent of resection is distributed equally between groups 
(χ2; p = 0.203), but in EndoCATS group the number of total 
resections is higher compared to ABBA and open procedures 
(96.6% vs. 75.0% and 81.1%; χ2: p < 0.001 and 0.001).
Perioperative data
The perioperative data of PS matched open and all endo-
scopic procedures are summarized in Table 3. The distri-
bution of resected specimen volume is significantly dif-
ferent in hemithyroidectomies (KW; p = 0.008), but only 
between EndoCATS and open procedures the difference is 
significant in post-hoc comparison (p = 0.006; EndoCATS 
vs. ABBA: p = 1.0; ABBA vs. open: p = 0.842). Regarding 
resected specimen volume, there is no significant difference 
between open and ABBA thyroidectomies (KW; p = 0.058). 
The histologic results are not distributed significantly differ-
ent between open and ABBA/EndoCATS procedures (χ2; 
p = 0.866) and endoscopic groups (χ2; p = 0.572); slightly 
Table 1  Questionnaire for patient’s satisfaction and cosmetic outcome



















more nodular goiters and less adenomas have been diag-
nosed in ABBA group.
The surgical times for hemithyroidectomies are shorter in 
open compared to endoscopic procedures (KW: p = 0.043), 
but without significant difference between open and Endo-
CATS or ABBA procedures in post-hoc comparison (KW; 
p = 0.139 and p = 0.126). The surgical time is significant 
longer for ABBA compared to open thyroidectomies (KW: 
p = 0.003). For thyroidectomies or hemi-thyroidectomies, 
there is no correlation of surgical time and volume of the 
resected specimen (r = 0.10 and 0.01). One-way ANOVA 
showed a significant difference between groups regarding 
length of hospital stay (KW; p = 0.001). In post-hoc multiple 
comparison hospital stay was significantly shorter in Endo-
CATS versus ABBA and EndoCATS versus open thyroid 
surgeries (p = 0.002 and 0.003), but not in ABBA vs. open 
procedures (p = 1.0).
Perioperative complications
The perioperative outcome is summarized in Table 3. There 
were no conversions from endoscopic to open surgery. Only 
one wound infection was observed in an axillary wound after 
an ABBA procedure; the wound had to be opened to heal 
by secondary intention (1.9%). Temporary numbness in 
48.1% and paresthesia in 64% along the access route to the 
thyroid space were observed in both ABBA and EndoCATS 
procedures without a significant difference between groups 
(χ2; p = 0.083). Local access related but clinical not relevant 
hematoma was found significantly more often in ABBA 
50.0% than in EndoCATS 28.8% procedures (χ2; p = 0.022).
There was one case of acute hemorrhage in each endo-
scopic group, which needed surgical revision on the day 
of surgery. In the EndoCATS case (1.7%) diffuse bleed-
ing could be managed endoscopically. The ABBA patient 
developed a swelling and “globus sensation”. The hematoma 
could be released by a small incision at bedside. The rates for 
bleeding complications showed no difference between open 
and ABBA/EndoCATS procedures (χ2; p = 0.708). In open 
procedures there were n = 3 cases of bleeding complications 
with need for revision (2.7%), only two were urgent, whereas 
in one case revision surgery was carried out on 6th POD 
without signs of potentially fatal hemorrhage. In ABBA 
procedures there was one surgical removal of a hematoma 
along the access site (1.9%) and in the EndoCATS group we 
performed one surgical revision of the access (1.7%) along 
the sternocleidomastoid muscle to release local symptoms 
on POD 2.
No case of permanent hypoparathyroidism occurred. The 
rates of temporary hypoparathyroidism showed no signifi-
cant difference between the open and endoscopic groups 
(χ2; p = 0.151), although the rates were higher in ABBA 
Table 2  Baseline demographic and perioperative data of all groups: open procedures, open procedures after propensity score matching (PS 
matched for: sex, type of resection and extent of resection), all endoscopic procedures, ABBA and EndoCATS procedures
p values are corrected by Bonferroni correction in case of multiple comparisons
*Significant at p < 0.05 (KW Kruskal Wallis one-way ANOVA, χ2) between PS matched open and all endoscopic procedures
All open procedures PS-matched open proce-
dures
All endoscopic ABBA EndoCATS
Number procedures/
patients
N = 225/225 N = 111/111 N = 111/109 N = 52 /52 N = 59/57
Age* (KW; p < 0.001), 
(PS:KW; p < 0.001)
59.0 ± 12.2 (14–84) 56.5 ± 13.3 (14–77) 46.32 ± 11.1 (19–75) 48.4 ± 12.0 (19–73) 44.5 ± 10.0 (20–75)
Sex (χ2; p < 0.001), (PS:χ2; p = 0.757)
 Female 151 (67.1%) 105 (94.6%) 106 (95.5%) 52 (100%) 54 (91.5%)
 Male 74 (32.9%) 6 (5.4%) 5 (4.5%) 0 5 (8.5%)
ASA score* (χ2; p < 0.001), (PS:χ2; p = 0.005)
 1 99 (44.0%) 55 (49.5%) 72 (64.9%) 26 (50.0%) 46 (78.0%)
 2 99 (44.0%) 41 (36.9%) 36 (32.4%) 23 (44.2%) 13 (22.0%)
 3 27 (12.0%) 15 (13.5%) 3 (2.7%) 3 (5.8%) 0
Type of resection* (χ2; p < 0.001) (PS:χ2; p = 0.043)
 Hemithyroidectomy 74 (32.9%) 54 (48.6%) 69 (62.2%) 10 (19.2%) 59 (100%)
 Thyroidectomy 151 (67.1%) 57 (51.4%) 42 (37.8%) 42 (80.8%) 0
Extent of resection (χ2; p = 0.157), (PS:χ2; p = 0.203)
 Total 190 (84.4%) 90 (81.1%) 96 (86.5%) 39 (75.0%) 57 (96.6%)
 Subtotal 3 (1.3%) 0 0 0 0
 Near total 1 (0.4%) 1 (0.9%) 3 (2.7%) 1 (1.9%) 2 (3.4%)
 Dunhill procedure 31 (13.8%) 20 (18.0%) 12 (10.8%) 12 (23.1%) 0
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and open procedures (9.6% vs. 4.5% vs. 1.7%). Temporary 
hypoparathyroidism occurred significantly more often in 
thyroidectomies compared to hemithyroidectomies irrespec-
tive of open or endoscopic access (χ2; p = 0.011).
There are no significant differences regarding tempo-
rary/permanent RLN palsies between open (2.7%/0.9%), 
ABBA (1.9%/1.9%) /EndoCATS (3.4%/1.7%) procedures 
(χ2; p = 0.893/0.840) and when comparing the two endo-
scopic groups (χ2; p = 0.634/0.928). Neither the extent of 
resection nor the type of surgical procedure (thyroidectomies 
vs. hemithyroidectomies) showed a significant impact on the 
rates of RLN palsies (χ2; p = 0.071 and 0.610) or bleeding 
complications (χ2; p = 0.488/0.834).
The rates of intraoperative complications like loss of sig-
nal using neuromonitoring or major bleeding was without 
difference between the open and EndoCATS/ABBA proce-
dures (χ2; p = 741), nor between the two endoscopic groups 
(χ2; p = 0.495).
Table 3  Baseline data of PS-matched open versus ABBA and EndoCATS cohort and perioperative outcome
p values are corrected by Bonferroni correction in case of multiple comparisons
NAM Nervus auricularis magnus, NCT nervus transversus colli, temp temporary, perm permanent
*Significant at p < 0.05 (KW: Kruskal Wallis one-way ANOVA, χ2, n.a not available for all values = 0)
PS-matched open procedures All endoscopic 
(ABBA + EndoCATS)
ABBA EndoCATS
Number of procedures N = 111 N = 111/109 N = 52 N = 59
Resected volume
  Totala (KW; p < 0.001) 49.8 ± 41.0 (3 –180) 29.1 ± 21.2 (4–102) 40.8 ± 23.2 (5–102) 18.8 ± 12.3 (4–63)
  Hemithyroidectomya (KW; 
p = 0.008)
38.7 ± 40.2 (3–180) 20.2 ± 15.9 (4–102) 27.8 ± 28.2 (5–102) 18.8 ± 12.3 (4–63)
 Thyroidectomy (KW; p = 0.058) 61.5 ± 38.8 (12–164) 44.3 ± 20.8 (13–94) 44.3 ± 20.8 (13–94)
Histologic result (χ2; p = 0.866)
 Nodular goiter 82 (73.9%) 80 (72.1%) 40 (76.9%) 40 (67.8%)
 Follicular adenoma 17 (15.3%) 18 (16.2%) 6 (11.5%) 12 (20.3%)
 Thyreoiditis 5 (4.5%) 7 (6.3%) 3 (5.8%) 4 (6.8%)
 Grave’s disease 3 (2.7%) 1 (0.9%) 1 (1.9%) 0
 Differentiated carcinoma 4 (3.6%) 5 (4.5%) 2 (3.8%) 3 (5.1%)
Surgical time
  Totala (KW: p < 0.001) 141.9 ± 67.1 (61–503) 152.4 ± 50.8 (60–375) 175.9 ± 54.0 (94–375) 131.6 ± 37.5 (60–223)
 Hemithyroidectomies (KW: 
p = 0.043)
123.1 ± 54.7 (61–272) 134.4 ± 39.2 (60–223) 150.8 ± 46.4 (94–220) 131.6 ± 37.5 (60–223)
  Thyroidectomies* (KW: p = 0.003) 157.4 ± 70.3 (67–503) 181.8 ± 54.3 (110–375) 181.8 ± 54.3 (110–375)
Hospital  stay* (KW; p = 0.001) 2.6 ± 1.0 (1–7) 2.4 ± 0.8 (1–6) 2.7 ± 0.9 (2–6) 2.2 ± 0.6 (1–5)
Access related complications
 Infection (χ2; p = 0.285) 0 1 (0.9%) 1 (1.9%) 0
 Temporary numbness (χ2; 
p = 0.083)
63 (56.8%) 25 (48.1%) 38 (64.4%) (NAM, NTC)
 Superficial  hematoma* (χ2; 
p = 0.022)
43 (38.7%) 26 (50%) 17 (28.8%)
General complications
 Surgical revision for hematoma 
(χ2; p = 0.920)
3 (2.7%) 4 (3.6%) 2 (3.8%) 2 (3.4%)
 Cervical hemorrhage (χ2; 
p = 0.996)
2 (1.8%) 2 (1.8%) 1 (1.9%) 1 (1.7%)
 Temp. Hypoparathyroidism (χ2; 
p = 0.151)
5 (4.5%) 6 (5.4%) 5 (9.6%) 1 (1.7%)
 Perm. Hypoparathyroidism (χ2; 
n.a.)
0 0 0 0
 Temp. RLN palsy (χ2; p = 0.893) 3 (2.7%) 3 (2.7%) 1 (1.9%) 2 (3.4%)
 Perm. RLN palsy (χ2; p = 0.840) 1 (0.9%) 2 (1.8%) 1 (1.9%) 1 (1.7%)
 Intraoperative complications (χ2; 
p = 0.741)
5 (4.5%) 6 (5.4%) 4 (7.7%) 2 (3.8%)
 Surgical Endoscopy
1 3
Follow‑up and patient‑reported outcome measures
Follow-up rate for ABBA and EndoCATS procedures was 
92.3% and 88.1% respectively (χ2; p = 0.321). Duration of 
follow-up was longer for ABBA (23.7 ± 12.2 month) than for 
EndoCATS procedures (15.0 ± 7.2 month; MW: p < 0.001) 
(Table 4). Only 60.4% of ABBA and 50% of EndoCATS 
patients had a laryngoscopy performed postoperatively (χ2; 
p = 0.011). All patients with perioperative major compli-
cations (bleeding complications, temporary hypoparathy-
roidism, intra operative loss of signal or RLN palsy) took 
part in follow-up. Patients lost to follow-up all belonged to 
the group with an uneventful intra- and postoperative course. 
All patients with loss of signal during intra operative nerve 
monitoring had at least one postoperative laryngoscopy, 
therefore, only patients with an intact RLN and vagus nerve 
signal in neuromonitoring were lost to follow-up.
89.6% and 94.2% of patients, respectively, were satisfied 
with the surgical procedure in the ABBA and the EndoCATS 
groups without significant difference in distribution between 
endoscopic groups (χ2; p = 0.191). The cosmetic result was 
rated with best two grades in 95.7% and 94.1% of patients in 
ABBA and EndoCATS procedures; there was no significant 
difference in distribution between groups (χ2; p = 0.506). 
92.7% of ABBA and 92.3% of EndoCATS patients would 
consider undergoing endoscopic surgery by the same tech-
nique again (χ2; p = 0.426), whereas only 8.3% of ABBA 
and 7.7% of EndoCATS patients would refuse this (Table 4).
Regarding QoL by SF-12 questionnaire, there was an 
overall difference for physical but not for mental health com-
posite scales between the groups (KW; p < 0.001 and 0.658). 
In post-hoc multiple comparison there was no significant 
difference between the non-surgical control group vs. Endo-
CATS (p = 0.528) and ABBA (p = 0.398), but between Endo-
CATS and ABBA compared to the German reference cohort 
(p = 0.002 and 0.001). As shown in Table 5 and Fig. 1, the 
endoscopic groups perform slightly worse regarding physi-
cal health compared to the non-surgical patients and Ger-
man reference cohort; this effect was only small according 
to the effect size for ABBA (d = − 0.359) and EndoCATS 
(d = − 0.323).
Discussion
Here, we present for the first-time clinical results directly 
comparing two remote approaches in thyroid surgery regard-
ing perioperative outcome and quality of life. Remote access 
endoscopic thyroid surgery has recently been shown to be 
safe and efficient not only in treatment of benign disease, but 
also for differentiated thyroid cancer [3, 7, 9, 20, 38].
We were able to show a decent peri- and postoperative 
outcome following the endoscopic procedures comparable 
to conventional open thyroid resections. The complica-
tion rates were very similar for all three groups, with no 
cases of permanent hypoparathyroidsm and only one case 
Table 4  Follow-up and long-
term outcome for endoscopic 
groups
a Significant at p < 0.05 (MW Mann Whitney U test, χ2)
ABBA EndoCATS
Number procedures/patients N = 52 N = 59/57
Follow-up rate(χ2; p = 0.321) 48 (92.3%) 52 (88.1%)
Follow-up duration (month)a (MW; p < 0.001) 23.7 ± 12.2 (6–28) 15.0 ± 7.2 (8–42)
Postoperative  laryngoscopya (χ2; p = 0.011) 29 (60.4%) 26 (50%)
Patient satisfaction (χ2; p = 0.191)
 Very satisfied 34 (71%) 45 (86%)
 Satisfied 9 (19%) 4 (8%)
 Slightly satisfied 5 (10%) 2 (4%)
 Not satisfied 0 1 (2%)
Rating of cosmetic result (χ2; p = 0.506)
 1 37 (78%) 43 (84%)
 2 8 (18%) 5 (10%)
 3 1 (2%) 0
 4 1 (2%) 2 (4%)
 5 0 0
 6 0 1 (2%)
Would patients choose this surgical technique again (χ2; p = 0.426)
 Yes 39 (82%) 46 (88%)
 Maybe 5 (10%) 2 (4%)
 No 4 (8%) 4 (8%)
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of permanent RLN palsy in each of the ABBA and Endo-
CATS groups. Acute hemorrhage occurred in only one case 
of each group, as well. Only in ABBA group there was one 
case of wound infection, which needed surgical revision. 
In both endoscopic remote access techniques, there was a 
rather a high rate of specific access related complications 
like numbness or superficial hematoma with skin discol-
orations, which were, however, only temporary in nature. 
Such local complications have also been described in con-
ventional open thyroidectomy procedures. Here they are, 
however, usually not of special interest since these are well 
established standard of care techniques [10, 12, 25, 38, 39]. 
We used endoscopic techniques in a highly selected patient 
collective, most patients underwent surgery for suspicious 
or symptomatic thyroid nodules or inflammatory thyroid 
disease.
Other groups report less favorable results using a RA, 
especially regarding the rates of RLN palsies (up to 4.4%), 
bleeding complications (up to 4.8%) with longer in hospital 
stays of about 4.4 days [12, 16] and similar surgical time 
for hemithyroidectomies of about 129 min by mean [12]. 
These groups use a much larger skin incision creating a skin 
flap predominantly in robotic—but also in endoscopic RA 
thyroid surgery techniques [8, 11, 24, 26]. Lira et al. report 
their results in robotic RA thyroid surgery, making up only 
a small fraction of 1.7% of all thyroidectomy procedures, 
a high rate of female patients (90%) with a mean age of 
35 years and rates of 6.2% for temporary RLN palsy and 
6.2% of temporary hypocalcemia [20]. Lee et al. compared 
the RA approach to the transaxillary one in hemithyroidecto-
mies only with a similar sample size [12]. In our department, 
we use the RA usually for unilateral endoscopic cases. This 
technique has its obvious limitation, mostly due to the sin-
gle port approach and limited surgical space as the midline 
is not opened like in ABBA, open or transoral techniques. 
However, with the advantage of a smaller dissection area 
and an excellent view on the RLN and the parathyroids. We 
use the transaxillary ABBA approach mostly for bilateral 
resections and in some unilateral cases with large speci-
men sizes or in rare situations, if patients prefer ABBA to 
EndoCATS approach. In our data the number of Dunhill, 
total, sub- and near-total resections were distributed equally 
over the groups, only the size of the resected specimen was 
smaller especially in EndoCATS procedures but also in the 
Table 5  Quality of life according to SF-12 questionnaire and comparison between MCS and PCS groups with Kruskal Wallis one-way ANOVA 
with post-hoc multiple comparisons
Non-surgical control cohort German control cohort
MCS 48.8 ± 9.6 MCS 50.97 ± 8.8

















MCS KW (comparison of all groups): p=0.658#
ABBA 49.5 ± 9.5 d=-0.438 d=-0.172
EndoCATS 50.0 ± 9.5 d=-0.383 d=-0.111
PCS KW (comparison of all groups): p<0.001*








Mean values ± standard deviation
MCS mental health composite scale, PSC physical health composite scale
*Significant at p < 0.05 (KW: Kruskal Wallis one-way ANOVA; d = effect size; all p-values are corrected by Bonferroni correction for multiple 
comparisons)
#No p values available for comparison between separate groups as KW shows no overall significant difference for MCS and therefore no post-
hoc multiple comparison was performed
Fig. 1  SF-12 scores for EndoCATS, ABBA, non-surgical control and 
German reference cohorts: comparison by Kruskal–Wallis one-way 
ANOVA: mental health composite scale: p = 0.658, physical health 
composite scale: p < 0.001 (only significant p-values are shown for 
post-hoc multiple comparison between groups)
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ABBA group compared to conventional open hemi- and thy-
roidectomies; only the difference for hemithyroidectomies 
was significant.
For ABBA and other transaxillary approaches compara-
ble complication rates have been reported in literature with 
rates of RLN palsy between 0 and 3.4%, bleeding compli-
cations around 3.5% and temporary hypocalcemia in up to 
23% of cases [15, 16, 18]. Independent of surgical technique, 
rates of temporary hypoparathyroidism were expectedly 
higher in thyroidectomies compared to hemithyroidecto-
mies, but especially in ABBA technique the rate was quite 
high (9.6%).
EndoCATS and ABBA are very different procedures that 
can only be compared to some extent. In our opinion, they 
are complementary, which enables us to offer our patients 
a tailored solution regarding personal preference, surgical 
technique and an approach depending on underlaying dis-
ease and extent of indicated surgical procedure. Despite the 
fact that the perioperative outcome of endoscopic “remote 
access” thyroid surgery can be considered favorable regard-
ing the common complications, all experts advise to pay 
attention to a meticulous patient selection, to ensure an 
adequate expertise in high volume centers and to respect 
the indications for thyroid surgery as given by the national 
and international guidelines [2, 3, 34, 35]. Taken together 
these recommendations and our experience, we suggest 
remote-access procedures for young patients without rel-
evant comorbidities who want to avoid a visible scar in the 
neck. The thyroid pathologies should be well-circumscribed 
like suspicious nodules including early stage differentiated 
thyroid cancers without any sign of extrathyroidal extension 
or lymph node involvement.
In both of our endoscopic groups 3.8% (ABBA) and 5.1% 
(EndoCATS) of the cases, respectively, were histologically 
diagnosed with differentiated thyroid carcinoma. Four of 
the five cases were sufficiently treated with the endoscopic 
procedure alone. Only one case with a T3 papillary thyroid 
carcinoma needed open revision with central lymph node 
dissection, which wouldn’t have been possible using the 
unilateral RA. Other groups mostly in the Asian countries 
have been using endoscopic and robotic techniques in treat-
ment of differentiated thyroid cancer for years with excellent 
outcomes. They do not only perform thyroidectomies but 
also central and lateral lymph node dissections with similar 
outcomes compared to conventional open procedures regard-
ing lymph node retrieval and long-term patient survival [25, 
28, 38, 40, 41]. Altogether, the endoscopic techniques turned 
out to be safe and effective not only in benign thyroid disor-
ders, but also for limited thyroid malignancies. Nonetheless, 
they are not recommended for treatment of thyroid cancer 
by German or International guidelines [34, 35]. The Ameri-
can Thyroid Association published a statement on remote 
access surgery in 2016 considering extrathyroidal spread 
or lymph node involvement as clear contraindications for 
remote access thyroid surgery. On the other hand, they stated 
a favorable outcome not only for papillary microcarcinoma 
but also for other differentiated thyroid cancers and report at 
least comparable number of retrieved lymph nodes in robotic 
thyroid cancer surgery [2].
A clear advantage of the remote access techniques com-
pared to conventional open thyroid surgery is the cosmetic 
result without a visible scar in the neck. Therefore, patients 
undergoing endoscopic thyroid surgery were significantly 
younger, healthier and the number of female patients was 
significantly higher compared to standard open procedures, 
the latter before propensity score matching. More than 90% 
of our patients in both endoscopic groups were satisfied with 
the cosmetic result. Only 2% of patients were not satisfied 
in the EndoCATS group. The cosmetic result was graded 
with two best grades (1 or 2) in more than 94% of patients in 
both endoscopic groups. Only 8% of patients in both endo-
scopic groups would not undergo the same surgical pro-
cedure again. Regarding the rating of cosmetic results, no 
comparable data are available in literature for endoscopic or 
remote access thyroid surgery. Patient satisfaction was quite 
high in our endoscopic groups. Satisfaction rates between 76 
and 99% are also reported by Chung for RA and Miccoli for 
MIVAT procedures [7, 39]. Remote access thyroid surgery is 
mostly asked for by young female patients [3, 8, 10, 25, 41, 
42] making up 95% of all patients in our study. The patients 
asking for endoscopic and in general remote access thyroid 
surgery without visible scars in the neck are a highly selec-
tive collective of patients with high expectations and a clear, 
if certainly idiosyncratic, idea of physical integrity.
In contrast to other available studies on perioperative 
outcome and cosmetic or general patient satisfaction with 
endoscopic or remote access thyroid surgery, we additionally 
used the SF-12 questionnaire to objectify our patient’s qual-
ity of life. For endoscopic or robotic thyroid surgery there 
are yet no comparable data available. Our patients showed 
a similar QoL between the two endoscopic groups and our 
controls in follow-up at least regarding mental health. For 
physical health composite scales, we could detect a statistical 
difference between endoscopic groups and German control 
cohort with significance in the post-hoc multiple comparison 
between single groups, but only small effect size, indicat-
ing a slightly worse outcome. We lack data on preoperative 
quality of life of our patients and for the open thyroid pro-
cedures, so that a more in-depth comparison of the groups 
is not possible. Some recent published studies address the 
question of QoL after open thyroid surgery. Van Velsen et al. 
showed a significant decrease of QoL after surgery which 
took up to 3 years to normalize to the baseline scoring in 
a cohort of 185 patients with differentiated thyroid cancer 
[43]. In women with benign euthyroid goiter, Promberger 
et al. did not find an overall improvement in health related 
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QoL after undergoing thyroid surgery [44]. In a recently 
published randomized controlled trial, QoL significantly 
increased after surgery in a cohort with euthyreotic Hashi-
moto’s disease compared to a cohort only receiving hormone 
substitution alone [45]. Altogether, QoL data in thyroid sur-
gery are sparse to find in literature and in the available data 
most patients perform worse in different aspects of QoL with 
thyroid disease and even after thyroid surgery for years in 
benign or malign disease [43, 44, 46–48]. Therefore, the 
decrease especially in physical health composite scale, may 
not be due to the surgery itself. Based on the sparse data 
on QoL presently available [43–46, 48] it might be related 
to a problem in mostly young and female patients, who are 
impaired by thyroid disease in general.
The SF-12 QoL as well as the more detailed SF-36ques-
tionnaires are widely used as validated and reliable tools, 
which can help to objectify patient’s QoL. They seem, how-
ever, unspecific regarding endocrinologic or especially thy-
roid disorders, since QoL depends not only on clinical but 
also on socio-demographic factors [33]. The data published 
so far lack consistency, as they all use different tools for 
evaluation of QoL or patients’ satisfaction. Nonetheless, 
these patient-reported outcomes become more and more 
important, especially for the evaluation of newly developed 
surgical techniques. Recently, a specialized tool named “thy-
roid-related quality of life—ThyPRO” for thyroid disease-
related QoL was published [49]; a widespread use of the 
same established QoL tool in thyroid disease and surgery 
would be helpful for reliable comparisons of available, not 
only surgical, treatment options.
There are several limitations in this work. One is that we 
reported the outcome of only a small number of patients in 
a highly selected collective from a single center. However, 
other groups also report only a small number of cases with 
a low degree of evidence [8, 10, 12, 18, 20, 21, 25, 39–42]. 
Furthermore, there is a bias due to patient selection for either 
one of the endoscopic or open procedures, as the EndoCATS 
approach can only be used for unilateral resections, whereas 
the ABBA technique is suitable for uni- and bilateral resec-
tions but only in female patients. Therefore, propensity score 
matching was used between open and endoscopic proce-
dures to minimize confounding bias and increase reliability 
of the here presented results [37]. Nonetheless, the endo-
scopic surgical techniques were used in a highly selected 
much younger, healthy cohort with a high number of female 
patients with selected thyroid pathologies and small resec-
tion volumes. Therefore, after propensity score matching 
some inhomogeneity remained between the open and endo-
scopic groups especially regarding type of resection, as with 
the endoscopic techniques in total 62% of procedures have 
been hemithyroidectomies compared to 33% in the conven-
tional open baseline cohort. The prospective follow-up was 
only available for about 90% of our endoscopically treated 
patients, so we cannot exclude some selection bias regarding 
the patient reported data dealing with patient satisfaction, 
rating of the cosmetic result and QoL. Furthermore, only 
about 50% of patients performed the recommended post-
operative laryngoscopy, but at least all patients with RLN 
palsy or intraoperative loss-of-signal in neuromonitoring 
had at least one postoperative laryngoscopy performed. As 
we documented patient satisfaction, rating of the cosmetic 
result and QoL data for the endoscopic cohort prospectively 
after surgical intervention only, no comparable data for con-
ventional open surgical procedures are available for a more 
comprehensive comparison.
Despite the fact, that the endoscopic techniques offer an 
excellent view on the surgical field due to video-endoscopy 
and the associated enlargement effect, these procedures are 
known to have a prolonged learning curve and for patient’s 
safety need to be performed by a specialized surgeon in 
high-volume centers [3, 11, 16]. On the other hand, only 
specimen of limited volume can be retrieved due to the 
remote approach and limited skin incisions; therefore, not 
all patients are suitable for these remote approach tech-
niques. Surgical times are longer in endoscopic compared 
to open thyroid surgery, but time seems to decrease after 
completing the learning curve [16]. Neither in Germany nor 
internationally, the remote access procedures have not yet 
been included in the guidelines for the treatment of at least 
differentiated thyroid cancer. In Asian countries, however, 
endoscopic techniques are already well established not only 
for the radical resection of cancer but also for central as well 
as selective lateral lymph node dissection in thyroid cancer 
patients [11, 25, 28, 29, 38, 40, 41, 50]. In Europe there have 
been some first successful experiences with the transaxil-
lary robotic approach in selected patients with differentiated 
thyroid cancer for thyroid resection and central lymph node 
dissection [51].
Conclusion
With regard to the recently published data on remote access 
thyroid surgery, a tailored approach with a feasible and save 
procedure associated with good cosmetic results for at least 
benign thyroid disease in a mostly young and female popula-
tion is possible using different techniques of endoscopic thy-
roid surgery in a single high-volume center. Remote access 
endoscopic thyroid surgery like EndoCATS and ABBA 
procedures can be safely performed with an excellent cos-
metic outcome and highly satisfied patients. The QoL in 
these patients is impaired, but presumably independent of 
surgery or surgical technique [43, 44, 46, 47].
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